chrX-32448508-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004006.3(DMD):​c.3734C>T​(p.Thr1245Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0116 in 1,206,985 control chromosomes in the GnomAD database, including 169 homozygotes. There are 4,240 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T1245T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0099 ( 14 hom., 315 hem., cov: 23)
Exomes 𝑓: 0.012 ( 155 hom. 3925 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

5
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 6.09

Publications

7 publications found
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
DMD Gene-Disease associations (from GenCC):
  • Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • dilated cardiomyopathy 3B
    Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Duchenne and Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Duchenne muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • progressive muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0023860931).
BP6
Variant X-32448508-G-A is Benign according to our data. Variant chrX-32448508-G-A is described in ClinVar as Benign. ClinVar VariationId is 94604.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0798 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DMDNM_004006.3 linkc.3734C>T p.Thr1245Ile missense_variant Exon 27 of 79 ENST00000357033.9 NP_003997.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DMDENST00000357033.9 linkc.3734C>T p.Thr1245Ile missense_variant Exon 27 of 79 1 NM_004006.3 ENSP00000354923.3

Frequencies

GnomAD3 genomes
AF:
0.00995
AC:
1105
AN:
111014
Hom.:
14
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00212
Gnomad AMI
AF:
0.00872
Gnomad AMR
AF:
0.0401
Gnomad ASJ
AF:
0.0103
Gnomad EAS
AF:
0.000285
Gnomad SAS
AF:
0.00184
Gnomad FIN
AF:
0.00295
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0104
Gnomad OTH
AF:
0.0149
GnomAD2 exomes
AF:
0.0189
AC:
3452
AN:
182401
AF XY:
0.0144
show subpopulations
Gnomad AFR exome
AF:
0.00199
Gnomad AMR exome
AF:
0.0894
Gnomad ASJ exome
AF:
0.00820
Gnomad EAS exome
AF:
0.000217
Gnomad FIN exome
AF:
0.00438
Gnomad NFE exome
AF:
0.00919
Gnomad OTH exome
AF:
0.0127
GnomAD4 exome
AF:
0.0118
AC:
12882
AN:
1095919
Hom.:
155
Cov.:
30
AF XY:
0.0108
AC XY:
3925
AN XY:
362543
show subpopulations
African (AFR)
AF:
0.00153
AC:
40
AN:
26226
American (AMR)
AF:
0.0823
AC:
2894
AN:
35149
Ashkenazi Jewish (ASJ)
AF:
0.00877
AC:
169
AN:
19278
East Asian (EAS)
AF:
0.0000664
AC:
2
AN:
30135
South Asian (SAS)
AF:
0.00288
AC:
156
AN:
54083
European-Finnish (FIN)
AF:
0.00370
AC:
150
AN:
40493
Middle Eastern (MID)
AF:
0.00291
AC:
12
AN:
4117
European-Non Finnish (NFE)
AF:
0.0107
AC:
9021
AN:
840495
Other (OTH)
AF:
0.00953
AC:
438
AN:
45943
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
457
914
1372
1829
2286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
390
780
1170
1560
1950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00995
AC:
1105
AN:
111066
Hom.:
14
Cov.:
23
AF XY:
0.00935
AC XY:
315
AN XY:
33694
show subpopulations
African (AFR)
AF:
0.00211
AC:
65
AN:
30757
American (AMR)
AF:
0.0400
AC:
417
AN:
10424
Ashkenazi Jewish (ASJ)
AF:
0.0103
AC:
27
AN:
2617
East Asian (EAS)
AF:
0.000286
AC:
1
AN:
3500
South Asian (SAS)
AF:
0.00184
AC:
5
AN:
2713
European-Finnish (FIN)
AF:
0.00295
AC:
18
AN:
6103
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.0104
AC:
544
AN:
52547
Other (OTH)
AF:
0.0147
AC:
22
AN:
1499
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
37
73
110
146
183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0103
Hom.:
633
Bravo
AF:
0.0143
TwinsUK
AF:
0.0108
AC:
40
ALSPAC
AF:
0.0135
AC:
39
ESP6500AA
AF:
0.00183
AC:
7
ESP6500EA
AF:
0.0109
AC:
73
ExAC
AF:
0.0139
AC:
1686
EpiCase
AF:
0.0104
EpiControl
AF:
0.00845

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Thr1245Ile in exon 27 of DMD: This variant is not expected to have clinical si gnificance because it has been identified in 1.1% (73/6728) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu /EVS/; dbSNP rs1800269). -

Mar 12, 2020
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: DMD c.3734C>T (p.Thr1245Ile) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.019 in 182401 control chromosomes, predominantly at a frequency of 0.089 within the Latino subpopulation in the gnomAD database, including 112 homozygotes and 971 hemizygotes. The observed variant frequency within Latino control individuals in the gnomAD database is significantly higher than expected for a pathogenic variant in DMD causing Dystrophinopathies phenotype, strongly suggesting that the variant is a benign polymorphism found primarily in populations of Latino origin. Six ClinVar submitters (evaluation after 2014) cite the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 10, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 14, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 19, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Benign:1
Apr 21, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dilated cardiomyopathy 3B Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Cardiovascular phenotype Benign:1
Jun 19, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Duchenne muscular dystrophy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.32
.;T;.;.
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.89
D;.;D;D
MetaRNN
Benign
0.0024
T;T;T;T
MetaSVM
Benign
-0.96
T
PhyloP100
6.1
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-1.7
.;N;.;N
REVEL
Benign
0.12
Sift
Benign
0.044
.;D;.;D
Sift4G
Uncertain
0.049
D;D;D;D
Polyphen
0.83
.;P;.;.
Vest4
0.31
MPC
0.019
ClinPred
0.036
T
GERP RS
3.1
gMVP
0.15
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800269; hg19: chrX-32466625; COSMIC: COSV63803746; API